Floatz logo

Nanatinostat

EBV Related PTCL, NOS

Viracta Therapeutics, Inc.Small moleculePhase 2Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

136 Active assets in the EBV Related PTCL, NOS cohort.

Asset / SponsorPhaseRating
Inno-206
BeBetter Med Inc
Phase 4BBB
PREDNISONE TABLETS
Tarapeutics Science Inc.
Phase 4BBB
Pralatrexate
Peking University People's Hospital
Phase 4BBB
(+)-VINCRISTINE
BeBetter Med Inc
Phase 4BBB
Cyclophosphamide
Tarapeutics Science Inc.
Phase 4BBB

View all 50 →

Same molecule, other indications

Nanatinostat is also rated in:

Epstein-Barr virus-associated lymphoproliferative disorderDormant
CCC
Indicative ·
49 / 100
View asset →
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderlyDormant
CC
Indicative ·
43 / 100
View asset →
Hodgkins lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →